Clinical Potential of Eluxadoline in the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome
Therapeutics and Clinical Risk Management
doi 10.2147/tcrm.s83722
Full Text
Open PDFAbstract
Available in full text
Date
May 1, 2016
Authors
Publisher
Informa UK Limited